
Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurre... Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.205 | 1.05970535022 | 19.345 | 20.32 | 19 | 341314 | 19.61078652 | CS |
4 | 0.77 | 4.10010649627 | 18.78 | 20.9 | 18.12 | 611391 | 19.82337688 | CS |
12 | -2.685 | -12.075556555 | 22.235 | 22.48 | 17.82 | 469855 | 19.88590418 | CS |
26 | -6.48 | -24.89435267 | 26.03 | 28.15 | 17.82 | 402708 | 22.2668336 | CS |
52 | -0.29 | -1.46169354839 | 19.84 | 28.15 | 16.56 | 414888 | 21.5433285 | CS |
156 | 8.69 | 80.0184162063 | 10.86 | 28.15 | 7.36 | 396319 | 16.79771772 | CS |
260 | 1.35 | 7.41758241758 | 18.2 | 33 | 7.36 | 396078 | 16.69636597 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約